Skip to main content

Imiquimod Topical Dosage

Medically reviewed by Drugs.com. Last updated on May 27, 2024.

Applies to the following strengths: 5%; 3.75%; 2.5%

Usual Adult Dose for Keratosis

2.5% and 3.75% cream: Apply a thin film once a day before bedtime to the affected area (either entire face or balding scalp)

Comments:


5% cream: Apply topically to the affected area on the face or scalp (but not both concurrently) 2 times per week for a full 16 weeks

Comments:

Use: For topical treatment of clinically typical visible or palpable actinic keratoses of the full face or balding scalp in immunocompetent patients

Usual Adult Dose for Condylomata Acuminata

3.75% cream: Apply a thin layer once a day to the external genital/perianal warts until total clearance or up to 8 weeks

Comments:


5% cream: Apply topically to external genital/perianal warts 3 times per week

Comments:

Use: For the treatment of external genital and perianal warts (EGW)/condyloma acuminate

Usual Adult Dose for Basal Cell Carcinoma

5% cream: Apply topical to a biopsy-confirmed superficial basal cell carcinoma 5 times per week for a full 6 weeks

Comments:


Use: For the topical treatment of biopsy-confirmed, primary superficial basal cell carcinoma (sBCC) in immunocompetent adults, with a maximum tumor diameter of 2 cm, located on the trunk (excluding anogenital skin), neck, or extremities (excluding hands and feet), only when surgical methods are medically less appropriate and patient follow-up can be reasonably assured

Usual Pediatric Dose for Condylomata Acuminata

12 years or older:
3.75% cream: Apply a thin layer once a day to the external genital/perianal warts until total clearance or up to 8 weeks

Comments:


12 years or older:
5% cream: Apply topically to external genital/perianal warts 3 times per week

Comments:

Use: For the treatment of external genital and perianal warts (EGW)/condyloma acuminate

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 12 years for the treatment of external genital warts.

Safety and efficacy have not been established in patients younger than 18 years for the treatment of actinic keratosis or superficial basal cell carcinoma.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

General:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.